|
|
 |
vistagen.com |
|
|
|
vistagen.com |
| drug : 2.91 % Board : 2.33 % Contact : 2.33 % candidates : 2.33 % stem : 1.74 % Trials : 1.74 % Test : 1.74 % Our : 1.74 % Clinical : 1.74 % cell : 1.74 % Home : 1.74 % toxicity : 1.74 % Info : 1.16 % Releases : 1.16 % Collaborators : 1.16 % Press : 1.16 % that : 1.16 % potential : 1.16 % Model : 1.16 % designed : 1.16 % VistaGen : 1.16 % D™ : 1.16 % Request : 1.16 % Investor : 1.16 % rescue : 1.16 % Resources : 1.16 % Technology : 1.16 % Stem : 1.16 % Profile : 1.16 % Business : 1.16 % Careers : 1.16 % Directors : 1.16 % Scientific : 1.16 % Advisory : 1.16 % Corporate : 1.16 % Management : 1.16 % Tube™ : 1.16 % CardioSafe : 1.16 % ™ : 1.16 % LiverSafe : 1.16 % About : 1.16 % Products : 1.16 % Basics : 1.16 % Cell : 1.16 % build : 0.58 % diverse : 0.58 % variants” : 0.58 % “drug : 0.58 % pipeline : 0.58 % their : 0.58 % positive : 0.58 % despite : 0.58 % concerns : 0.58 % efficacy : 0.58 % data : 0.58 % benefits : 0.58 % therapeutic : 0.58 % signaling : 0.58 % goal : 0.58 % reserved : 0.58 % rights : 0.58 % All : 0.58 % place : 0.58 % due : 0.58 % Powered : 0.58 % Systems : 0.58 % Web : 0.58 % first : 0.58 % shelf : 0.58 % but : 0.58 % original : 0.58 % without : 0.58 % caused : 0.58 % put : 0.58 % them : 0.58 % effective : 0.58 % prediction : 0.58 % Human : 0.58 % platform : 0.58 % biology : 0.58 % Tube : 0.58 % provide : 0.58 % indication : 0.58 % early : 0.58 % integrated : 0.58 % technologies : 0.58 % biotechnology : 0.58 % Inc : 0.58 % Therapeutics : 0.58 % company : 0.58 % focused : 0.58 % proprietary : 0.58 % using : 0.58 % cardiac : 0.58 % before : 0.58 % been : 0.58 % have : 0.58 % promising : 0.58 % previously : 0.58 % “put : 0.58 % pharmaceutical : 0.58 % shelf” : 0.58 % variants : 0.58 % safer : 0.58 % tested : 0.58 % ever : 0.58 % humans : 0.58 % technology : 0.58 % new : 0.58 % identify : 0.58 % companies : 0.58 % | Trials Test : 1.63 % stem cell : 1.63 % Clinical Trials : 1.63 % drug candidates : 1.63 % D ™ : 1.09 % AV Business : 1.09 % Tube™ CardioSafe : 1.09 % Test Tube™ : 1.09 % Model Collaborators : 1.09 % Products Clinical : 1.09 % Press Releases : 1.09 % Request Investor : 1.09 % Investor Contact : 1.09 % Info Request : 1.09 % Resources Info : 1.09 % Basics Products : 1.09 % Releases Resources : 1.09 % Collaborators Press : 1.09 % Business Model : 1.09 % Profile Management : 1.09 % Home Contact : 1.09 % Board Directors : 1.09 % Directors Scientific : 1.09 % Corporate Profile : 1.09 % Us Corporate : 1.09 % Cell Basics : 1.09 % Contact About : 1.09 % About Us : 1.09 % Scientific Advisory : 1.09 % Management Board : 1.09 % Board Careers : 1.09 % Careers Technology : 1.09 % Stem Cell : 1.09 % Advisory Board : 1.09 % Technology Stem : 1.09 % goal build : 0.54 % build diverse : 0.54 % Our goal : 0.54 % benefits Our : 0.54 % therapeutic benefits : 0.54 % shelf” by : 0.54 % diverse drug : 0.54 % rescue variants” : 0.54 % variants” that : 0.54 % pipeline “drug : 0.54 % drug pipeline : 0.54 % “drug rescue : 0.54 % that as : 0.54 % concerns despite : 0.54 % due toxicity : 0.54 % as effective : 0.54 % companies due : 0.54 % pharmaceutical companies : 0.54 % by pharmaceutical : 0.54 % toxicity concerns : 0.54 % despite positive : 0.54 % signaling their : 0.54 % their potential : 0.54 % data signaling : 0.54 % efficacy data : 0.54 % positive efficacy : 0.54 % potential therapeutic : 0.54 % rights reserved : 0.54 % Powered By : 0.54 % By Q : 0.54 % reserved Powered : 0.54 % “put shelf” : 0.54 % All rights : 0.54 % Q Web : 0.54 % Web Systems : 0.54 % LiverSafe D™ : 0.54 % D™ AV : 0.54 % D™ LiverSafe : 0.54 % CardioSafe D™ : 0.54 % Systems Home : 0.54 % place All : 0.54 % first place : 0.54 % but without : 0.54 % without toxicity : 0.54 % candidates but : 0.54 % original drug : 0.54 % as original : 0.54 % toxicity that : 0.54 % that caused : 0.54 % put shelf : 0.54 % shelf first : 0.54 % be put : 0.54 % them be : 0.54 % caused them : 0.54 % effective as : 0.54 % before ever : 0.54 % rescue Our : 0.54 % Our integrated : 0.54 % drug rescue : 0.54 % technologies drug : 0.54 % cell technologies : 0.54 % integrated stem : 0.54 % cell biology : 0.54 % Test Tube : 0.54 % Tube designed : 0.54 % Human Clinical : 0.54 % platform Human : 0.54 % biology platform : 0.54 % proprietary stem : 0.54 % using proprietary : 0.54 % LiverSafe D : 0.54 % ™ AV : 0.54 % ™ LiverSafe : 0.54 % CardioSafe D : 0.54 % Home Home : 0.54 % Contact VistaGen : 0.54 % VistaGen Therapeutics : 0.54 % company focused : 0.54 % focused using : 0.54 % biotechnology company : 0.54 % Inc biotechnology : 0.54 % Therapeutics Inc : 0.54 % designed provide : 0.54 % provide early : 0.54 % identify new : 0.54 % new safer : 0.54 % designed identify : 0.54 % technology designed : 0.54 % cell technology : 0.54 % safer variants : 0.54 % variants promising : 0.54 % have been : 0.54 % been previously : 0.54 % candidates have : 0.54 % candidates candidates : 0.54 % promising drug : 0.54 % Our stem : 0.54 % humans Our : 0.54 % prediction potential : 0.54 % potential cardiac : 0.54 % or prediction : 0.54 % indication or : 0.54 % early indication : 0.54 % cardiac toxicity : 0.54 % toxicity drug : 0.54 % tested humans : 0.54 % ever tested : 0.54 % VistaGen Home : 0.54 % candidates before : 0.54 % previously “put : 0.54 % | Clinical Trials Test : 1.64 % Trials Test Tube™ : 1.09 % AV Business Model : 1.09 % Products Clinical Trials : 1.09 % Cell Basics Products : 1.09 % Basics Products Clinical : 1.09 % Business Model Collaborators : 1.09 % Model Collaborators Press : 1.09 % Info Request Investor : 1.09 % Request Investor Contact : 1.09 % Resources Info Request : 1.09 % Releases Resources Info : 1.09 % Collaborators Press Releases : 1.09 % Press Releases Resources : 1.09 % Stem Cell Basics : 1.09 % Test Tube™ CardioSafe : 1.09 % Corporate Profile Management : 1.09 % Profile Management Board : 1.09 % Management Board Directors : 1.09 % Us Corporate Profile : 1.09 % About Us Corporate : 1.09 % Home Contact About : 1.09 % Contact About Us : 1.09 % Technology Stem Cell : 1.09 % Board Directors Scientific : 1.09 % Advisory Board Careers : 1.09 % Board Careers Technology : 1.09 % Careers Technology Stem : 1.09 % Directors Scientific Advisory : 1.09 % Scientific Advisory Board : 1.09 % benefits Our goal : 0.55 % Our goal build : 0.55 % therapeutic benefits Our : 0.55 % potential therapeutic benefits : 0.55 % signaling their potential : 0.55 % their potential therapeutic : 0.55 % variants” that as : 0.55 % drug pipeline “drug : 0.55 % data signaling their : 0.55 % rescue variants” that : 0.55 % goal build diverse : 0.55 % pipeline “drug rescue : 0.55 % diverse drug pipeline : 0.55 % build diverse drug : 0.55 % “drug rescue variants” : 0.55 % companies due toxicity : 0.55 % shelf” by pharmaceutical : 0.55 % by pharmaceutical companies : 0.55 % “put shelf” by : 0.55 % previously “put shelf” : 0.55 % have been previously : 0.55 % been previously “put : 0.55 % pharmaceutical companies due : 0.55 % that as effective : 0.55 % despite positive efficacy : 0.55 % positive efficacy data : 0.55 % concerns despite positive : 0.55 % toxicity concerns despite : 0.55 % due toxicity concerns : 0.55 % efficacy data signaling : 0.55 % first place All : 0.55 % Powered By Q : 0.55 % By Q Web : 0.55 % reserved Powered By : 0.55 % rights reserved Powered : 0.55 % place All rights : 0.55 % All rights reserved : 0.55 % Q Web Systems : 0.55 % Web Systems Home : 0.55 % LiverSafe D™ AV : 0.55 % D™ AV Business : 0.55 % D™ LiverSafe D™ : 0.55 % CardioSafe D™ LiverSafe : 0.55 % Systems Home Contact : 0.55 % Tube™ CardioSafe D™ : 0.55 % candidates have been : 0.55 % shelf first place : 0.55 % candidates but without : 0.55 % but without toxicity : 0.55 % drug candidates but : 0.55 % original drug candidates : 0.55 % effective as original : 0.55 % as original drug : 0.55 % without toxicity that : 0.55 % toxicity that caused : 0.55 % be put shelf : 0.55 % put shelf first : 0.55 % them be put : 0.55 % caused them be : 0.55 % that caused them : 0.55 % as effective as : 0.55 % before ever tested : 0.55 % cell technologies drug : 0.55 % technologies drug rescue : 0.55 % stem cell technologies : 0.55 % proprietary stem cell : 0.55 % focused using proprietary : 0.55 % using proprietary stem : 0.55 % drug rescue Our : 0.55 % rescue Our integrated : 0.55 % biology platform Human : 0.55 % platform Human Clinical : 0.55 % cell biology platform : 0.55 % stem cell biology : 0.55 % Our integrated stem : 0.55 % integrated stem cell : 0.55 % company focused using : 0.55 % biotechnology company focused : 0.55 % ™ LiverSafe D : 0.55 % LiverSafe D ™ : 0.55 % D ™ LiverSafe : 0.55 % CardioSafe D ™ : 0.55 % Home Home Contact : 0.55 % Tube™ CardioSafe D : 0.55 % D ™ AV : 0.55 % ™ AV Business : 0.55 % Therapeutics Inc biotechnology : 0.55 % Inc biotechnology company : 0.55 % VistaGen Therapeutics Inc : 0.55 % Contact VistaGen Therapeutics : 0.55 % Investor Contact VistaGen : 0.55 % Human Clinical Trials : 0.55 % Trials Test Tube : 0.55 % cell technology designed : 0.55 % technology designed identify : 0.55 % stem cell technology : 0.55 % Our stem cell : 0.55 % tested humans Our : 0.55 % humans Our stem : 0.55 % designed identify new : 0.55 % identify new safer : 0.55 % promising drug candidates : 0.55 % drug candidates candidates : 0.55 % variants promising drug : 0.55 % safer variants promising : 0.55 % new safer variants : 0.55 % ever tested humans : 0.55 % VistaGen Home Home : 0.55 % early indication or : 0.55 % indication or prediction : 0.55 % provide early indication : 0.55 % designed provide early : 0.55 % Test Tube designed : 0.55 % Tube designed provide : 0.55 % or prediction potential : 0.55 % prediction potential cardiac : 0.55 % drug candidates before : 0.55 % candidates before ever : 0.55 % toxicity drug candidates : 0.55 % cardiac toxicity drug : 0.55 % potential cardiac toxicity : 0.55 % candidates candidates have : 0.55 % |
| Total: 276 |
| vistagyn.com vishtagen.com gistagen.com vistagenn.com rvistagen.com nvistagen.com visthagen.com vikstagen.com jvistagen.com ivistagen.com visturgen.com vitagen.com vistaigen.com vistageb.com visyagen.com 0vistagen.com vistagren.com viystagen.com vi9stagen.com visgtagen.com visatgen.com vestagen.com dvistagen.com vistagen0.com viostagen.com v9stagen.com vistagen3.com vistagsen.com vistagen5.com visttagen.com vistdagen.com xvistagen.com vistyagen.com 3vistagen.com vistagjen.com vjstagen.com viswtagen.com vstagen.com vistqagen.com vijstagen.com 4vistagen.com vistaen.com vistagben.com vistwagen.com lvistagen.com vistagem.com vistager.com fvistagen.com vistag3en.com vistagesn.com vistfagen.com vistagene.com vistagern.com vustagen.com vistgen.com viestagen.com vis6tagen.com ovistagen.com vistgaen.com vistagenw.com vkistagen.com vfistagen.com vistag4n.com vistzgen.com vistaogen.com vistagean.com vistogen.com avistagen.com vistagenl.com vistageno.com 1vistagen.com visatagen.com vistagen.com vist5agen.com vistageni.com viztagen.com vyestagen.com vistaggen.com vistagrn.com wwwvistagen.com vicstagen.com vistqgen.com wvistagen.com vistage4n.com vistagenes.com vistuagen.com v8istagen.com visagen.com visrtagen.com ivstagen.com vkstagen.com vistagsn.com vistageng.com vsitagen.com vittagen.com vistageyn.com vistagenf.com vvistagen.com vistigen.com vistahen.com vistygen.com vistragen.com hvistagen.com vistagven.com vistagenz.com vistaegn.com vist6agen.com vistagent.com viatagen.com vistaven.com vcistagen.com 2vistagen.com vistagn.com vistagun.com vistagaen.com vistageon.com vistagen4.com vistagien.com vistag4en.com vistagenu.com vistagon.com vjistagen.com vistzagen.com fistagen.com vgistagen.com visftagen.com vidtagen.com vistagenx.com vuistagen.com viwtagen.com uvistagen.com visfagen.com vis5agen.com cvistagen.com victagen.com vistagen8.com vistagetn.com vistagdn.com vissagen.com vistagewn.com v8stagen.com vistaqgen.com evistagen.com vitstagen.com vystagen.com vistaben.com visgagen.com vistasgen.com vistcagen.com vaistagen.com zvistagen.com vistagebn.com vistiagen.com tvistagen.com vistaagen.com 7vistagen.com vis5tagen.com vistagurn.com 5vistagen.com vistagain.com visdagen.com mvistagen.com vistagin.com vistageun.com vyistagen.com wwvistagen.com pvistagen.com vistagden.com vistagej.com vistgagen.com vistagenv.com vastagen.com bvistagen.com yvistagen.com vistagen6.com gvistagen.com vistagejn.com vistagenc.com vistagein.com vietagen.com voistagen.com vistagwn.com visdtagen.com vistagena.com wistagen.com viastagen.com vistagen2.com veistagen.com kvistagen.com vis6agen.com vostagen.com visytagen.com vistagne.com vistag3n.com vistagenj.com vistagfen.com visxtagen.com vistajen.com vistagten.com vistage.com viscagen.com vistage3n.com vitsagen.com vistadgen.com vistagend.com vistaegen.com 8vistagen.com veestagen.com visetagen.com vistagehn.com vistaten.com vistabgen.com vistajgen.com vistaghen.com vistaguen.com vistazgen.com viistagen.com vistagenp.com 6vistagen.com vi8stagen.com vistagenh.com visstagen.com vistagwen.com vistayen.com vistageny.com visteagen.com vistagenb.com qvistagen.com viwstagen.com visctagen.com vistaygen.com vistagoen.com vistugen.com visragen.com vistatgen.com vixstagen.com cistagen.com vistagen7.com vixtagen.com vistagenk.com v9istagen.com vistavgen.com vbistagen.com vistsgen.com vishagen.com vistagyen.com vistahgen.com vistagedn.com 9vistagen.com vizstagen.com vistargen.com svistagen.com vistagens.com vistoagen.com vistafen.com vistagen9.com bistagen.com vidstagen.com viustagen.com vistagemn.com vistaugen.com vistagenq.com vistagen1.com istagen.com vwistagen.com vistafgen.com vistageh.com vistagenm.com vistwgen.com vistawgen.com vistageen.com vistsagen.com vistagenr.com visztagen.com vistagan.com vistegen.com |